Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Growth Differentiation Factor-15 May Be A Novel Biomarker In Pancreatic Cancer: A Review

Growth differentiation factor-15 may be a novel biomarker in pancreatic cancer: A review

Meng Guo1, Hui Zhao

  • 1Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Medicine
|February 9, 2024

Related Experiment Videos

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

799
Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models
03:42

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models

Published on: September 27, 2024

1.4K
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.3K

View abstract on PubMed

Summary
This summary is machine-generated.

Growth Differentiation Factor-15 (GDF-15) shows promise as a novel biomarker for pancreatic cancer, potentially improving diagnosis and prognosis beyond current markers like CA199. This review explores GDF-15

Area of Science:

  • Oncology and Gastroenterology
  • Biomarker Discovery

Background:

  • Pancreatic cancer is aggressive, often detected late, with poor outcomes.
  • Current biomarker Carbohydrate Antigen 199 (CA199) has significant limitations for pancreatic cancer diagnosis.
  • There is a critical need for improved diagnostic and prognostic tools.

Approach:

  • Systematic literature review of GDF-15 and CA199 in pancreatic cancer.
  • Keywords: GDF-15, MIC-1, CA199, pancreatic cancer, tumor markers.
  • Analysis of GDF-15 characteristics, mechanism, and clinical utility.

Key Points:

  • Growth Differentiation Factor-15 (GDF-15) demonstrates potential as a novel pancreatic cancer biomarker.
  • GDF-15 may aid in diagnosis, predicting treatment efficacy, and assessing patient prognosis.

Related Experiment Videos

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

799
Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models
03:42

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models

Published on: September 27, 2024

1.4K
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.3K
  • Its clinical value warrants further investigation for pancreatic cancer management.

    • Conclusions:

    • GDF-15 presents a promising alternative or adjunct to CA199 for pancreatic cancer.
    • Further research into GDF-15's role can enhance early detection and treatment strategies.
    • This review provides insights into GDF-15 for pancreatic cancer detection and treatment.